Mercer Island, WA, United States of America

David W Leung

This inventor holds 28 USPTO granted patents and 1 published patent application, primarily in Biologics Development. Top assignees: Cell Therapeutics, Inc., Genentech, Inc., Fred Hutchinson Cancer Center. Active years: 1988-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David W Leung. Retrieved from https://idiyas.com/inventor/david-w-leung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28 

% Patents Active = 71.4

Average Co-Inventor Count = 2.9

ph-index = 11

Forward Citations = 820(Granted Patents)


Location History:

  • So. San Francisco, CA (US) (1988)
  • Foster, CA (US) (1989)
  • Foster City, CA (US) (1991 - 1998)
  • Mercer Island, WA (US) (1997 - 2014)

Company Filing History:


Years Active: 1988-2014

Loading Chart...
Areas of Expertise:
Polypeptide Conjugates
LPAAT-β Inhibitors
Growth Hormone Receptor
Phosphatidic Acid Phosphatase
Vascular Endothelial Growth Factor
Neurodegenerative Treatment
Immunological Modulation
CDP-Diacylglycerol Synthase
28 patents (USPTO):Explore Patents

Title: Innovator Spotlight: David W Leung Revolutionizes Biologically Active Protein Conjugates

Introduction: David W Leung, a pioneering inventor based in Mercer Island, WA, has made significant contributions to the field of biologically active protein conjugates. With a remarkable portfolio of 28 patents, Leung's innovative work has reshaped the landscape of biotechnology.

Latest Patents: Leung's latest patents focus on conjugates of biologically active polypeptides with increased in vivo half-life. By coupling a biologically active polypeptide to a repeating peptide motif, Leung's conjugates exhibit modified plasma half-life, enhancing the effectiveness of the underlying proteins. These groundbreaking methods open new possibilities for drug delivery and therapeutic applications.

Career Highlights: Leung has established himself as a key figure in the biotech industry, having worked with renowned companies such as Cell Therapeutics, Inc. and Genentech, Inc. His expertise and innovative approach have led to the development of cutting-edge therapies that have the potential to revolutionize the healthcare sector.

Collaborations: Throughout his career, Leung has collaborated with esteemed professionals in the field, including David M Hollenback and J Peter Klein. These partnerships have been instrumental in advancing research and fostering a culture of innovation within the industry.

Conclusion: David W Leung's relentless pursuit of innovation and commitment to excellence have positioned him as a trailblazer in the field of biologically active protein conjugates. His groundbreaking work continues to inspire and pave the way for future advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…